MedPath

Comparison of Two Laser Therapy Methods for PDR

Phase 2
Conditions
Proiriftrative Diabetic Retinopathy
Interventions
Procedure: conventional prp
Procedure: targeted prp
Registration Number
NCT01232179
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Proliferative diabetic retinopathy (PDR) is treated with conventional pan retinal photocoagulation (PRP) which can improve the visual prognosis in this complication significantly. However , the treatment may also resulting adverse effects such as blurring of central vision, visual field constriction and disturbance in dark adaptation and contrast vision. Extended targeted retinal coagulation (TRP) to the ischemic areas may cause regression of the neovascularization while minimizing some of the risks and complication associated of treatment of PDR with these two methods.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • patients with PDR condidate for photocoagulation teraphy
  • Pupil with dilatasion≥6mm
  • without privious treatment with anti VEGF drugs 3months before study
  • without privious vitroretinal sugery
  • without privoius lasertraphy
Exclusion Criteria
  • To have NVI cricteria with increase of inraocular pressure
  • to have cataract or vitrus leakage which prevent lasertraphy
  • pupil smaller that 6mm
  • traditional retinal detachment
  • privious treatment with anti VEGF drugs 3months before study
  • privious PRP
  • patient unable to get wide field FAG

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
conventional prpconventional prp-
targeted PRPtargeted prp-
Primary Outcome Measures
NameTimeMethod
no leakage in widefield fluorescin angiography3 months after lasertraphy
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Labbafinejad medical center

🇮🇷

Tehran, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath